Nuria López-Royuela

Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis

Patricia Balsas, Nuria López-Royuela, Patricia Galán‐Malo et al. · Biochemical Pharmacology · 2008 · 54 citations · Full text

Hematological Malignancy, Apoptosis, Cell Death +3

All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity

Diego Sánchez‐Martínez, Ewelina Krzywińska, Moeez Rathore et al. · The International Journal of Biochemistry & Cell Biology · 2014 · 43 citations

Oncogenic Agent, Ctsc Expression, Immunology +9

The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism

Nerea Allende-Vega, Ewelina Krzywińska, Stefania Orecchioni et al. · Oncotarget · 2015 · 35 citations · Full text

Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells

Nuria López-Royuela, Patricia Pérez‐Galán, Patricia Galán‐Malo et al. · Biochemical Pharmacology · 2010 · 27 citations

P53-deficient Leukemia Cells, Medicine, Apoptosis +10

Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis

Ariel Ramírez-Labrada, Nuria López-Royuela, Vidal Jarauta et al. · Clinical & Translational Oncology · 2014 · 25 citations

Hematological Malignancy, Cancer Research, Medicine +11